Jul 2014

PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions

Petah Tikva, Israel, July 7, 2014. PolyPid, a developer of proprietary medical device and drug delivery solutions, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. application Serial Number 13/574,040, a patent covering compositions for sustained and/or controlled release of nucleic acid agents. A Notice…

Read more >
Jun 2014

PolyPid Wins First Prize at Biomed Startup Competition

Petah Tikva, Israel, June 18, 2014. PolyPid, a developer of proprietary medical device and drug delivery solutions, today announced that it won First Prize in the startup competition at MIXiii Biomed Israel Innovation Conference, held in Tel Aviv.The prize was awarded to PolyPid for the company’s “innovative and prominence solutions that answer a profound need and a…

Read more >

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >